Cleared Traditional

K071047 - MASIMO PATIENT SAFETY NET

K071047 is the FDA 510(k) clearance for MASIMO PATIENT SAFETY NET by Masimo Corporation. It is a Class 2 Cardiovascular device (product code MSX) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K071047 · Masimo Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2007
Decision
56d
Days
Class 2
Risk

K071047 is an FDA 510(k) clearance for the MASIMO PATIENT SAFETY NET. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Masimo Corporation (Irvine, US). The FDA issued a Cleared decision on June 8, 2007 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Masimo Corporation devices

Submission Details

510(k) Number K071047 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 2007
Decision Date June 08, 2007
Days to Decision 56 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 125d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 69
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K071047.
PHILIPS TELEMEDICINE SERVER/SYSTEM, MODEL 861441
K091176 · Philips Medical Systems · Nov 2009
HYPERVISOR VI CENTRAL MONITORING SYSTEM (INCLUDING TMS)
K080192 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Apr 2008
PHILIPS HEARTSTART 12 LEAD TRANSFER STATION, MODEL 989803142521
K071391 · Philips Medical Systems, Inc. · Sep 2007
DATEX-OHMEDA S/5 DEVICE INTERFACING SOLUTION, N-DISXXXX..01 WITH N-DISVENT..02
K070421 · Ge Healthcare · Mar 2007
PMP4 APPLICATION
K061428 · Card Guard Scientific Survival , Ltd. · Oct 2006
SPACELABS MEDICAL CLINICAL EVENT INTERFACE, MODEL 91847
K062278 · Spacelabs Medical, Inc. · Sep 2006